By Isa Abdul, Abuja

The first generic version of lenacapavir, a twice-yearly injection used to prevent HIV infection, has been given tentative approval by the U.S. Food and Drug Administration (FDA), in a major development for global HIV prevention.

The generic drug which has been developed by India’s Dr Reddy’s Laboratories, and is expected to cost about $40 per person annually, will be made available across 120 low- and middle-income countries, including Nigeria.

The injection has demonstrated near-total effectiveness in clinical trials, offering an alternative to daily HIV prevention pills. The approval is expected to accelerate access to affordable prevention options, although local regulatory processes, funding and distribution remain key to its rollout.

By Michael Lim

The Nigeria Centre for Disease Control (NCDC) has disclosed that the two suspected Ebola cases reported in Yola, Adamawa State, have tested negative following two rounds of laboratory testing.

The Agency noted in a statement that it is working with the Adamawa State Government to investigate the cases, which were isolated and tested.

The NCDC clarified that the index case previously confirmed in the Federal Capital Territory remains the only confirmed Ebola case reported in Nigeria.

It urged Nigerians to remain calm and rely on official government and public health channels for accurate information.

The Agency further advised anyone experiencing symptoms such as fever, severe weakness, headache, muscle pain, vomiting, diarrhoea or unexplained bleeding, particularly after possible exposure, to seek immediate medical attention and provide healthcare workers with relevant travel and contact history.

By Michael Lim

Two individuals have been isolated by health authorities following suspicion that they may be infected by Ebola disease in Nigeria’s North-East region as they are being subjected to investigations and lab tests.

An update on the disease situation by the Nigeria Centre for Disease Control and Prevention (NCDC), said contact identification and listing were ongoing, while samples from the suspected cases were being subjected to laboratory testing.

It clarified that the classification of the individuals as suspected cases did not mean they had tested positive for Ebola, noting that confirmation would depend on laboratory results.

The public was advised to maintain proper hand hygiene, practise enhanced sanitation and follow preventive guidance issued by public health authorities.

The update added that further information would be provided as verified details become available.